Role of exendin‐4 in the Gila monster: Further lessons regarding human oral glucagon‐like peptide‐1 therapy?
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.1111/dom.14171
Abstract: The discovery of glucagon-like peptide-1 (GLP-1) and demonstration of its insulin-releasing and glucose-lowering properties represent important milestones leading to the present drug exploitation of the GLP-1 receptor (GLP-1R) as a therapeutic target for both type… read more here.
Keywords: glp; insulin; gila monster; exendin ... See more keywords